A promiscuous inflammasome sparks replication of a common tumor virus
- 9 January 2020
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (3) , 1722-1730
Abstract
Viruses activate inflammasomes but then subvert resulting inflammatory responses to avoid elimination. We asked whether viruses could instead use such activated or primed inflammasomes to directly aid their propagation and spread. Since herpesviruses are experts at coopting cellular functions, we investigated whether Epstein−Barr virus (EBV), an oncoherpesvirus, exploits inflammasomes to activate its replicative or lytic phase. Indeed, our experiments reveal that EBV exploits several inflammasome sensors to actually activate its replicative phase from quiescence/latency. In particular, TXNIP, a key inflammasome intermediary, causes assembly of the NLRP3 inflammasome, resulting in caspase-1−mediated depletion of the heterochromatin-inducing epigenetic repressor KAP1/TRIM28 in a subpopulation of cells. As a result, only TXNIPhiKAP1lo cells, that is, in a primed/prolytic state, turn expression of the replication/lytic/reactivation switch protein on to enter the replicative phase. Our findings 1) demonstrate that EBV dovetails its escape strategy to a key cellular danger-sensing mechanism, 2) indicate that transcription may be regulated by KAP1 abundance aside from canonical regulation through its posttranslational modification, 3) mechanistically link diabetes, which frequently activates the NLRP3 inflammasome, to deregulation of a tumor virus, and 4) demonstrate that B lymphocytes from NOMID (neonatal onset multisystem inflammatory disease) patients who have NLRP3 mutations and suffer from hyperactive innate responses are defective in controlling a herpesvirus. Significance Infectious agents, including viruses, activate cellular inflammasomes. Viruses have evolved strategies to parry such host defense mechanisms, and cancer-causing gammaherpesviruses such as Epstein−Barr virus (EBV) are no exception. In distinct contrast, we show that this ubiquitous virus exploits assembly of the NLRP3 inflammasome to kick-start its lytic cascade; this allows EBV to reactivate from quiescence, propagate, and leave the cell when the cell perceives intrinsic or extrinsic threats. This discovery also provides a predictive signature that marks cells in which EBV is poised to enter the lytic phase. Importantly also, with hyperglycemia known to activate the NLRP3 inflammasome, our findings provide a mechanistic basis for recent clinical observations of diabetes as a significant risk factor for EBV-lymphomas in transplant recipients.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01 AI113134)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R41 AI115834)
This publication has 45 references indexed in Scilit:
- Mechanisms of disease: inflammasome activation and the development of type 2 diabetesFrontiers in Immunology, 2013
- Epstein-Barr Virus and Systemic Lupus ErythematosusJournal of Immunology Research, 2012
- An NLRP7-Containing Inflammasome Mediates Recognition of Microbial Lipopeptides in Human MacrophagesImmunity, 2012
- Valproic Acid Antagonizes the Capacity of Other Histone Deacetylase Inhibitors To Activate the Epstein-Barr Virus Lytic CycleJournal of Virology, 2011
- IFI16 Acts as a Nuclear Pathogen Sensor to Induce the Inflammasome in Response to Kaposi Sarcoma-Associated Herpesvirus InfectionCell Host & Microbe, 2011
- Discovery of a Viral NLR Homolog that Inhibits the InflammasomeScience, 2011
- A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of LymphomasJournal of Virology, 2011
- A Yersinia Effector Protein Promotes Virulence by Preventing Inflammasome Recognition of the Type III Secretion SystemCell Host & Microbe, 2010
- Activation of Inflammasomes Requires Intracellular Redistribution of the Apoptotic Speck-Like Protein Containing a Caspase Recruitment DomainThe Journal of Immunology, 2009
- The Interaction of Thioredoxin with TxnipJournal of Biological Chemistry, 2006